AB vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

AB

50.0
AI Score
VS
AB Wins

CNS

43.4
AI Score

Investment Advisor Scores

AB

50score
Recommendation
HOLD

CNS

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AB CNS Winner
Forward P/E 10.5708 23.0947 AB
PEG Ratio 0.6343 2.0603 AB
Revenue Growth -40.3% 12.2% CNS
Earnings Growth 20.9% 31.9% CNS
Tradestie Score 50.0/100 43.4/100 AB
Profit Margin 390.6% 28.8% AB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AB 1M: -2.4% · 3M: -5.0% CNS 1M: +1.8% · 3M: +12.8%

Current Technical Phase

AB

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 41

RSI (14): 41.4 · Price: $36.26

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

Fundamentals Snapshot

Metric AB CNS
Market Cap
Forward P/E 9.4 20.5
Trailing P/E 10.8 25.0
Revenue (TTM)
Revenue Growth -0.4% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 1.0% 0.3%
EPS 3.33 3.23
Dividend Yield 0.10% 0.03%

Frequently Asked Questions

Based on our detailed analysis, AB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.